Anavex Life Sciences Corp (AVXL)

[falconer66a]

Does The “Iceberg” Harbor Lots Of Human Diseases?

I’m betting that Anavex lab people have run a host of tests checking what their molecules do to aging rats and mice. And for very appropriate reasons they aren’t letting a sliver of what they’ve found become known beyond the locked lab doors.

At the simplest, most elemental, if Anavex 2-73 provides even just symptomatic stabilization of either Parkinson’s or Alzheimer’s it will be a pharmaceutical revolution. Very high chance, however, that at least for some, symptomatic remission will occur. Even more revolutionary.

But what if it turns out that organelle disconnections are the root, basal cause of most or all pathologies related to aging? And, what if any of the proprietary Anavex sigma-1 receptor agonists (not just Anavex 2-73) are able to either prevent organelle disconnections or restore youthful intracellular architectures? In the first case, debilities of aging could be prevented. In the latter, youthful stages of health could be restored.

I’m particularly interested in learning human applications of Anavex 3-71. Murine data with the molecule indicate that at least for some conditions it has higher levels of treatment efficacy than Anavex 2-73.

And Anavex Life Sciences Corp owns other unique sigma-1 receptor agonist molecules, awaiting eventual testing on diseased humans.

In the Anavex iceberg are there molecules that will slow normal aging processes, allowing humans to live healthfully well into their later decades? I’m betting (have bought a few hundred AVXLs) that Anavex researchers now know the answers to these “fountain (drug) of youth” questions. If positive, it’s not really an iceberg. It’s a continental glacier, which will flatten medical treatment landscapes.